BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24922644)

  • 1. Influence of hypoxia inducible factors on the immune microenvironment in ovarian cancer.
    Duechler M; Peczek L; Szubert M; Suzin J
    Anticancer Res; 2014 Jun; 34(6):2811-9. PubMed ID: 24922644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The heterogeneous immune microenvironment in breast cancer is affected by hypoxia-related genes.
    Duechler M; Peczek L; Zuk K; Zalesna I; Jeziorski A; Czyz M
    Immunobiology; 2014 Feb; 219(2):158-65. PubMed ID: 24091277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene.
    Horiuchi A; Hayashi T; Kikuchi N; Hayashi A; Fuseya C; Shiozawa T; Konishi I
    Int J Cancer; 2012 Oct; 131(8):1755-67. PubMed ID: 22287060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer.
    Wolf D; Wolf AM; Rumpold H; Fiegl H; Zeimet AG; Muller-Holzner E; Deibl M; Gastl G; Gunsilius E; Marth C
    Clin Cancer Res; 2005 Dec; 11(23):8326-31. PubMed ID: 16322292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of ovarian cancer type I and type II microenvironment on the phenotype and function of monocyte-derived dendritic cells.
    Surówka J; Wertel I; Okła K; Bednarek W; Tarkowski R; Kotarski J
    Clin Transl Oncol; 2017 Dec; 19(12):1489-1497. PubMed ID: 28589429
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sterol regulatory element-binding protein 1 is required for ovarian tumor growth.
    Nie LY; Lu QT; Li WH; Yang N; Dongol S; Zhang X; Jiang J
    Oncol Rep; 2013 Sep; 30(3):1346-54. PubMed ID: 23818099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CIP2A is overexpressed in human ovarian cancer and regulates cell proliferation and apoptosis.
    Fang Y; Li Z; Wang X; Zhang S
    Tumour Biol; 2012 Dec; 33(6):2299-306. PubMed ID: 22923389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Musashi-2 is a novel regulator of paclitaxel sensitivity in ovarian cancer cells.
    Lee J; An S; Choi YM; Lee J; Ahn KJ; Lee JH; Kim TJ; An IS; Bae S
    Int J Oncol; 2016 Nov; 49(5):1945-1952. PubMed ID: 27600258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hypoxia-inducible factor 1alpha, hypoxia-inducible factor 2alpha, and von Hippel-Lindau protein in epithelial ovarian neoplasms and allelic loss of von Hippel-Lindau gene: nuclear expression of hypoxia-inducible factor 1alpha is an independent prognostic factor in ovarian carcinoma.
    Osada R; Horiuchi A; Kikuchi N; Yoshida J; Hayashi A; Ota M; Katsuyama Y; Melillo G; Konishi I
    Hum Pathol; 2007 Sep; 38(9):1310-20. PubMed ID: 17555795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential transcriptional and protein expression of thyroid-stimulating hormone receptor in ovarian carcinomas.
    Gyftaki R; Liacos C; Politi E; Liontos M; Saltiki K; Papageorgiou T; Thomakos N; Haidopoulos D; Rodolakis A; Alevizaki M; Bamias A; Dimopoulos A
    Int J Gynecol Cancer; 2014 Jun; 24(5):851-6. PubMed ID: 24844218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periostin in tumor microenvironment is associated with poor prognosis and platinum resistance in epithelial ovarian carcinoma.
    Sung PL; Jan YH; Lin SC; Huang CC; Lin H; Wen KC; Chao KC; Lai CR; Wang PH; Chuang CM; Wu HH; Twu NF; Yen MS; Hsiao M; Huang CY
    Oncotarget; 2016 Jan; 7(4):4036-47. PubMed ID: 26716408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL17a and IL21 combined with surgical status predict the outcome of ovarian cancer patients.
    Chen YL; Chou CY; Chang MC; Lin HW; Huang CT; Hsieh SF; Chen CA; Cheng WF
    Endocr Relat Cancer; 2015 Oct; 22(5):703-11. PubMed ID: 26150382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELF5 in epithelial ovarian carcinoma tissues and biological behavior in ovarian carcinoma cells.
    Yan H; Qiu L; Xie X; Yang H; Liu Y; Lin X; Huang H
    Oncol Rep; 2017 Mar; 37(3):1412-1418. PubMed ID: 28184931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer-associated ascites demonstrates altered immune environment: implications for antitumor immunity.
    Giuntoli RL; Webb TJ; Zoso A; Rogers O; Diaz-Montes TP; Bristow RE; Oelke M
    Anticancer Res; 2009 Aug; 29(8):2875-84. PubMed ID: 19661290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in TP53 wild-type ovarian cancer cells.
    Mir R; Tortosa A; Martinez-Soler F; Vidal A; Condom E; Pérez-Perarnau A; Ruiz-Larroya T; Gil J; Giménez-Bonafé P
    Int J Cancer; 2013 Apr; 132(7):1525-36. PubMed ID: 22961628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinicopathological significance of Bax and Bcl-2 protein expression with tumor infiltrating lymphocytes in ovarian carcinoma.
    Yigit S; Demir L; Tarhan MO; Cabuk FK; Ellidokuz H; Erten C; Somali I; Dirican A; Cakalagaoglu F
    Neoplasma; 2012; 59(5):475-85. PubMed ID: 22668011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients.
    Okła K; Surówka J; Frąszczak K; Czerwonka A; Kaławaj K; Wawruszak A; Kotarski J; Wertel I
    Tumour Biol; 2018 Oct; 40(10):1010428318804937. PubMed ID: 30319054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of galectin-7 in epithelial ovarian cancer.
    Kim HJ; Jeon HK; Lee JK; Sung CO; Do IG; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
    Anticancer Res; 2013 Apr; 33(4):1555-61. PubMed ID: 23564797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weapons ovarian epithelial tumors may use in immune escape: an immunohistochemical correlational study.
    Hasby EA
    Pathol Oncol Res; 2012 Apr; 18(2):509-18. PubMed ID: 22161157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
    Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
    J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.